Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2006 Apr 27;18(2):119–129. doi: 10.1111/j.1365-2222.1988.tb02851.x

Influence of atopy on the clinical manifestations of coronavirus infection in adult volunteers

KATHLEEN A CALLOW 1,, D A J TYRRELL 1, R J SHAW 2, PENNY FITZHARRIS 2, A J WARDLAW 2, A B KAY 2
PMCID: PMC7194196  PMID: 2835193

Summary

In an attempt to understand the relationship between viral upper respiratory tract infection and the underlying virological and immunological mechanisms, thirty‐four volunteers were inoculated intranasally with coronavirus 229E; subsequent virus shedding and/or antibody rises, indicating active infection, were observed in twenty‐nine. There was a greater increase in independently measured scores of clinical severity, e.g. cold symptoms, in those with detectable IgE in nasal secretions (P < 0.01). A similar association was found between clinical scores and serum IgE concentrations 150 IU/ml, but the relationship with systemic atopy, as assessed by skin‐prick tests to common allergens, was less marked. A more detailed study of twelve of the infected volunteers failed to explain these findings on the basis of mast ceil mediator release, as concentrations of leukotriene B4, the sulphidopeptide leukotriene C4, and histamine, were not appreciably elevated in the nasal secretions following virus inoculation. Similarly, there was no evidence that circulating coronavirus specific IgE was produced. Thus, this study suggests that atopy may be related to the severity of cold symptoms produced by coronavirus 229E, although the exact connection has yet to be determined.

References

  • 1. Gregg I. Provocation of airflow limitation by viral infection: implication for treatment. Eur J Respir Dis 1983; 64 (suppl 128):369–79. [PubMed] [Google Scholar]
  • 2. Berg T, Johansson SGO. IgE concentrations in children with atopic diseases. Int Arch Allergy Appl Immunol 1969; 36:219–32. [DOI] [PubMed] [Google Scholar]
  • 3. Johansson SGO, Bennich H, Berg T, Hogman C. Some factors influencing the serum IgE levels in atopic diseases Clin Exp Immunol 1970; 6:43–7. [PMC free article] [PubMed] [Google Scholar]
  • 4. Wittig HJ, Belloit J, De Fillippi I, Royal G. Age‐related serum immunoglobulin E levels in healthy subjects and in patients with allergic disease. J Allergy Clin Immunol 1980; 66:305–13. [DOI] [PubMed] [Google Scholar]
  • 5. Barbee RA, Halonen M, Lebowitz M, Burrows B. Distribution or IgE in a community population sample: correlations with age, sex and allergen skin test reactivity. J Allergy Clin Immunol 1981; 68:106–11. [DOI] [PubMed] [Google Scholar]
  • 6. Johansson SGO, Deuschl H. Immunoglobulins in nasal secretion with special reference to IgE. Int Arch Allergy Appl Immunol 1976; 52:364–75. [DOI] [PubMed] [Google Scholar]
  • 7. Illum P, Balle V. Immunoglobulins in nasal secretions and nasal mucosa in perennial rhinitis. Acta Otolaryngol 1978; 86:135–41. [DOI] [PubMed] [Google Scholar]
  • 8. Merrett TG, Houri M, Mayer ALR, Merrett J. Measurement of specific IgE antibodies in nasal secretion—evidence for local production. Clin Allergy 1976; 6:69–73. [DOI] [PubMed] [Google Scholar]
  • 9. Creticos PS, Peters SP, Adkinson NF et al. Peptide leukotriene release after antigen challenge to patients sensitive to ragweed. N Engl J Med 1984; 310:1626–30. [DOI] [PubMed] [Google Scholar]
  • 10. Shaw RJ, Fitzharris P, Cromwell O, Wardlaw AJ, Kay AB. Allergen‐induced release of sulphidopeptide leukotrienes (SRS‐A) and LTB4 in allergic rhinitis. Allergy 1985; 40:1–6. [DOI] [PubMed] [Google Scholar]
  • 11. Welliver RC, Wong DT, Sun M, Middleton E Jr, Vaughan RS, Ogra PL. The development of respiratory syncytial virus‐specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med 1981; 305:841–6. [DOI] [PubMed] [Google Scholar]
  • 12. Welliver RC, Wong DT, Middleton E Jr, Sun M, McCarthy N, Ogra PL. Role of parainfluenza virus‐specific IgE in pathogenesis of croup and wheezing subsequent to infection. J Pediatr 1982; 101:6; 889–96. [DOI] [PubMed] [Google Scholar]
  • 13. Salonen E‐M, Hovi T. Meurman O, Vesikari T, Vaheri A. Kinetics of specific IgA, IgD, IgE, IgG and IgM antibody responses in rubella. J Med Virol 1985; 16:1–9. [DOI] [PubMed] [Google Scholar]
  • 14. Beare AS, Reed SE. The study of antiviral compounds in volunteers In: Oxford JS, ed. Chemoprophylaxis and Virus Infections of the Respiratory Tract. Vol II Cleveland : CRC Press, 1977:27–55. [Google Scholar]
  • 15. Higgins PG, Phillpotts RJ, Scott GM, Wallace J, Bernhardt LL, Tyrrell DAJ. Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteers. Antimicrob Agents Chemother 1983; 24:713–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Callow KA. Effect of specific humoral immunity and some non‐specific factors on resistance of volunteers to respiratory coronavirus infection. J Hyg Camb 1985; 95:173–89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Tyrrell DAJ. Common Cold and Related Diseases. London : Edward Arnold Ltd, 1965:51–2. [Google Scholar]
  • 18. Phillpotts RJ. Clones of MRC‐C cells may be superior to the parent line for the culture of 229E‐like strains of human respiratory coronavirus. J Virol Methods 1983; 6:267–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Zetterstrom O, Johansson SGO. IgE concentrations measured by PRIST in serum of healthy adults and in patients with respiratory allergy. Allergy 1981; 36:537–47. [DOI] [PubMed] [Google Scholar]
  • 20. Geha RS. Continuing medical education: human IgE. J Allergy Clin Immunol 1984; 74:109–22. [DOI] [PubMed] [Google Scholar]
  • 21. Cromwell O, Shaw RJ, Walsh GM, Mallet AI, Kay AB. Inhibition of leukotriene C4 and B4 generation by human eosinophils and neutrophils with the lipoxygenase pathway inhibitors U‐60,257 and BW755C. Int J Immunopharmacol 1985; 7:775–81. [DOI] [PubMed] [Google Scholar]
  • 22. Hayes EC, Lombardo DL, Girard Y el al. Measuring leukotrienes of slow reacting substance of anaphylaxis: development of a specific radio‐immunoassay. J Immunol 1983; 131:429–33. [PubMed] [Google Scholar]
  • 23. Shaw RJ, Cromwell O, Kay AB. Preferential generation of leukotriene C4 by human eosinophils. Clin Exp Immunol 1984; 56:716–22. [PMC free article] [PubMed] [Google Scholar]
  • 24. Guilloux L, Hartmann D, Ville G. Enzymatic isotopic assay for human plasma histamine. Clin Chim Acta 1981; 116:269–75. [DOI] [PubMed] [Google Scholar]
  • 25. Welliver RC, Sun M, Rinaldo D, Ogra PL. Respiratory syncytial virus‐specific IgE responses following infection: evidence for a predominantly mucosal response. Pediatr Res 1985; 19:420–4. [DOI] [PubMed] [Google Scholar]
  • 26. Houri M, Mayer ALR, Houghton LE, Jacobs D. Correlation of skin, nasal and inhalation tests with the IgE in the serum, nasal fluid and sputum. Clin Allergy 1972; 2:285–98. [DOI] [PubMed] [Google Scholar]
  • 27. Buckley CE, Larrick JW, Kaplan JE. Population differences in cutaneous methacholine reactivity and circulating IgE concentrations. J Allergy Clin Immunol 1985; 76:847–54. [DOI] [PubMed] [Google Scholar]
  • 28. Ishizaka K, Newcomb RW. Presence of γE in nasal washings and sputum from asthmatic patients. J Allergy 1970; 46:197–204. [DOI] [PubMed] [Google Scholar]
  • 29. Braun JJ, Pauli G, Bessot JC, Thierry R, Conraux C. Local and serum IgE in vasomotor rhinitis. Rhinology 1982; 20:3–12. [PubMed] [Google Scholar]
  • 30. Minor TE, Dick EC, Demeo AN, Ouellette JJ, Cohen M, Reed CE. Viruses as precipitants of asthmatic attacks in children. J Am Med Assoc 1974; 227:292–8. [PubMed] [Google Scholar]
  • 31. Minor TE, Dick EC, Baker JW, Ouellette JJ, Cohen M, Read CE. Rhinovirus and influenza type A infections as precipitants of asthma. Am Rev Respir Dis 1976; 113:149–53. [DOI] [PubMed] [Google Scholar]
  • 32. Halperin SA, Eggleston PA, Beasley P et al. Exacerbations of asthma in adults during experimental rhinovirus infection. Am Rev Respir Dis 1985; 132:976–80. [DOI] [PubMed] [Google Scholar]
  • 33. Katz DH. Regulation of the IgE system: experimental and clinical aspects. Allergy 1984; 39:81–106. [DOI] [PubMed] [Google Scholar]
  • 34. Rossen RD, Butler WT, Cate TR, Szwed CF, Couch RB. Protein composition of nasal secretion during respiratory virus infection. Proc Soc Exp Biol (NY) 1965; 119:1169–76. [DOI] [PubMed] [Google Scholar]
  • 35. Butler WT, Waldmann TA, Rossen RD, Gordon Douglas R Jr, Couch RB. Changes in IgA and IgG concentrations in nasal secretions prior to the appearance of antibody during viral respiratory infection in man. J Immunol 1970; 105:584–91. [PubMed] [Google Scholar]
  • 36. Naclerio RM, Proud D, Peters SP et al. Inflammatory mediators in nasal secretions during induced rhinitis. Clin Allergy 1986; 16:101–10. [DOI] [PubMed] [Google Scholar]
  • 37. Leung DVM, Geha RS. Regulation of IgE synthesis in man. Clin Immunol Rev 1984; 3:1–24. [PubMed] [Google Scholar]
  • 38. Haeney M. An introduction to allergic disease. London. J Roy Coll Physicians 1985; 19:147–53. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Allergy are provided here courtesy of Wiley

RESOURCES